Genentech's Associate Oncology Director Talks Cancer Vaccine Challenges
Executive Summary
Peter Fong, associate director of oncology business development at Genentech – a division of Roche – talks to Scrip about the company's latest deal with BioNTech in oncology vaccines and why Genentech is predicting success this time around for more cancer vaccine products, especially when used in combination with newer immunotherapy options.